On February 16, 2021, Mitch Zeller, Director of the FDA’s Center for Tobacco Products (CTP), published an update on FDA’s progress in handling the waterfall of applications for premarket authorization of new tobacco products (PMTA) and other applications from tobacco companies. Everyone was expecting a large number of PMTA applications for new products to comeContinue reading “FDA can streamline reviewing e-cigs as consumer tobacco products by starting with key questions about use”
Author Archives: Stanton Glantz
UCSF and Johns Hopkins University Launch Digital Trove of Opioid Industry Documents
The UCSF Truth Tobacco Documents Library is 20 years old and had led to over 1000 publications, including not only academic papers, media stories, documentaries and government reports. The tobacco documents have transformed the discussion of tobacco globally. Now, the UCSF LIbrary, working with Johns Hopkins, is launching a major expansion of a sister collectionContinue reading “UCSF and Johns Hopkins University Launch Digital Trove of Opioid Industry Documents”
Public comment supporting USPS regulation against mailing all e-cigs (including cannabis)
My colleagues at UCSF and Stanford and I just submitted the following public comment supporting Postal Service regulations to prohibit mailing e-cigarettes and their components to implement recent Congressional legislation. This not only includes nicotine devices but also non-nicotine devices, including cannabis. We also suggested some technical clarifications to make sure there are no loopholes.Continue reading “Public comment supporting USPS regulation against mailing all e-cigs (including cannabis)”
FDA should ignore Philip Morris request to tell public nicotine doesn’t cause cancer
Earlier this month Bloomberg reported that Philip Morris had asked FDA to convince Americans that nicotine isn’t that bad, citing research showing that most wrongly think that nicotine causes cancer. This effort seems part of Philip Morris effort to promote its IQOS heated tobacco product as well as Juul e-cigarettes (in which Altria, parent ofContinue reading “FDA should ignore Philip Morris request to tell public nicotine doesn’t cause cancer”
UK study shows nondaily ecig use associated with significantly less quitting cigs
A recent paper published in Addiction, “The effectiveness of using e-cigarettes for quitting smoking compared to other cessation methods among adults in the United Kingdom,” found that the odds of 30 day smoking cessation among smokers motivated to quit were cut by a factor or 4 among nondaily e-cig users compared to people who didContinue reading “UK study shows nondaily ecig use associated with significantly less quitting cigs”
FDA should take Puff Bar at its word that it is not a tobacco product … and ban them as illegal drug delivery devices
The 2009 Family Smoking Prevention and Tobacco Control Act gave the FDA jurisdiction to regulate tobacco products, defined as products “made or derived from tobacco.” This means that any product that includes nicotine derived from tobacco is subject to FDA jurisdiction. There has been discussion in academic circles about nicotine delivery products being made fromContinue reading “FDA should take Puff Bar at its word that it is not a tobacco product … and ban them as illegal drug delivery devices”
Altria moving toward entering US marijuana market
Altria (owner of Philip Morris) has made two moves to get ready to enter the US marijuana market. It registered to lobby on marijuana commercialization in Virginia and has submitted two US patents for cannabis vaporization devices. According to the report in Cannabis Wire, “Altria supports the federal legalization of cannabis under an appropriate regulatoryContinue reading “Altria moving toward entering US marijuana market”
Smoke-free laws and cigarette taxes impact smoking behavior trajectories in youth and young adults
All smokers’ behavior is not the same. We and others has identified five trajectories of smoking behavior over time among youth and young adults based on demographic characteristics (graph above). Now Dorie Apollonio, Lauren Dutra and I have expanded this work to include the effects of changing tobacco control policies — smokefree laws and taxesContinue reading “Smoke-free laws and cigarette taxes impact smoking behavior trajectories in youth and young adults”
More opioid industry documents being made public
Just as litigation against the tobacco companies beginning with the Minnesota settlement has led to over 90 million pages of previously secret tobacco industry documents being made public, the recent settlement between state attorneys general and with McKinsey Company will make internal McKinsey documents available to the public. The tobacco industry documents have led toContinue reading “More opioid industry documents being made public”
Biden facing moment of truth on menthol
Under pressure from the tobacco companies Congress exempted menthol from the ban on “characterizing flavors” in cigarettes and other regulated tobacco products when it passed the 2009 Family Smoking Prevention and Tobacco Control Act that gave FDA authority to regulate tobacco products. During the negotiations a group of former Secretaries of Health and others criticizedContinue reading “Biden facing moment of truth on menthol”
Stanton Glantz blog 